Verstraete Stephany's Form 4 filing
Teladoc Health, Inc. (TDOC) · filed Mar 4, 2022
- Accession no.
- 0001415889-22-002589
- Filed
- Mar 4, 2022
- Trade date
- Mar 2-3, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 7 derivative transactions. Open-market sales total $200.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Verstraete StephanyCIK 0001726419 | Officer (CHIEF MARKETING OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2022 | Common Stock | MOption exerciseAcquired | +1,808 | –F1 | – | 24,086 | Direct | |
| Mar 2, 2022 | Common Stock | MOption exerciseAcquired | +3,074 | –F2 | – | 27,160 | Direct | |
| Mar 2, 2022 | Common Stock | MOption exerciseAcquired | +773 | –F2 | – | 27,933 | Direct | |
| Mar 2, 2022 | Common Stock | MOption exerciseAcquired | +1,147 | –F1 | – | 29,080 | Direct | |
| Mar 2, 2022 | Common Stock | MOption exerciseAcquired | +868 | –F2 | – | 29,948 | Direct | |
| Mar 3, 2022 | Common Stock | SSaleDisposed | −2,858 | $70.24 | −$200,745.92 | 27,090 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2022 | Common Stock | MOption exerciseDisposed | −1,808 | $0.00 | $0 | 1,807 | Direct | |
| Mar 2, 2022 | Common Stock | MOption exerciseDisposed | −3,074 | $0.00 | $0 | 3,072 | Direct | |
| Mar 2, 2022 | Common Stock | AGrant or awardAcquired | +1,545 | $0.00 | $0 | 1,545 | Direct | |
| Mar 2, 2022 | Common Stock | MOption exerciseDisposed | −773 | $0.00 | $0 | 772 | Direct | |
| Mar 2, 2022 | Common Stock | MOption exerciseDisposed | −1,147 | $0.00 | $0 | 2,295 | Direct | |
| Mar 2, 2022 | Common Stock | AGrant or awardAcquired | +2,602 | $0.00 | $0 | 2,602 | Direct | |
| Mar 2, 2022 | Common Stock | MOption exerciseDisposed | −868 | $0.00 | $0 | 1,734 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Referenced by the price of 2 transactions in Table I.
- F2
Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
Referenced by the price of 3 transactions in Table I.